
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 International Agency for Research on Cancer, Lyon, France; 2 Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San José, Costa Rica; 3 Instituto Nacional de Cancerología, Bogota, Colombia; 4 VU University Medical Center, Amsterdam, the Netherlands; 5 Department of Epidemiology, University of North Carolina, Chapel Hill, North Carolina; 6 Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico; 7 Research Division, National Cancer Institute, Bangkok, Thailand; 8 Research Institute, National Cancer Centre, Ilsan-gu Koyang, Kyonggi, Goyang, Korea; 9 Servei d'Epidemiologia i Registre del Càncer Institut Català d'Oncologia, L'Hospitalet del Llobregat, Barcelona, Spain; 10 Instituto de Oncología Angel H. Roffo, Universidad de Buenos Aires, Buenos Aires, Argentina; 11 Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; 12 National Cancer Institute, Hoankiem District, Hanoi, Vietnam; and 13 College of Medicine, University of Ibadan, Ibadan, Nigeria
Requests for reprints: Salvatore Vaccarella, IARC, 150 cours Albert Thomas, 69372 Lyon cedex 08, France. Phone: 33-4-72-73-80-97; Fax: 33-4-72-73-83-45. E-mail: vaccarella{at}iarc.fr
Human papillomavirus (HPV) is a sexually transmitted infection but it is unclear whether differences in transmission efficacy exist between individual HPV types. Information on sexual behavior was collected from 11 areas in four continents among population-based, age-stratified random samples of women of ages
15 years. HPV testing was done using PCR-based enzyme immunoassay. Unconditional logistic regression was used to estimate odds ratios (OR) of being HPV positive and corresponding 95% confidence intervals (95% CI). Variables were analyzed categorically. When more than two groups were compared, floating confidence intervals were estimated by treating ORs as floating absolute risks. A total of 11,337 women (mean age, 41.9 years) were available. We confirmed that lifetime number of sexual partners is associated with HPV positivity (OR for
2 versus 1, 1.86; 95% CI, 1.63-2.11) but the association was not a linear one for HPV18, 31, and 33 (i.e., no clear increase for
3 versus 2 sexual partners). Women who had multiple-type infection and high-risk HPV type infection reported a statistically nonsignificant higher number of sexual partners than women who had single-type and low-risk type infections, respectively. Early age at sexual debut was not significantly related to HPV positivity. Husband's extramarital sexual relationships were associated with an OR of 1.45 (95% CI, 1.24-1.70) for HPV positivity in their wives after adjustment for age and lifetime number of women's sexual partners. We did not observe a significant association with condom use. Our study showed an effect of both women's and their husbands' sexual behavior on HPV positivity. Furthermore, it suggests some differences in the pattern of the association between sexual behavior and different HPV types.(Cancer Epidemiol Biomarkers Prev 2006;15(2):32633)
This article has been cited by other articles:
![]() |
B. Dondog, G. M. Clifford, S. Vaccarella, T. Waterboer, D. Unurjargal, D. Avirmed, S. Enkhtuya, F. Kommoss, N. Wentzensen, P. J.F. Snijders, et al. Human Papillomavirus Infection in Ulaanbaatar, Mongolia: A Population-Based Study Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1731 - 1738. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vaccarella, R. Herrero, P. J F Snijders, M. Dai, J. O Thomas, N. T. Hieu, C. Ferreccio, E. Matos, H. Posso, S. de Sanjose, et al. Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys Int. J. Epidemiol., June 1, 2008; 37(3): 536 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Syrjanen, I. Shabalova, N. Petrovichev, V. Kozachenko, T. Zakharova, J. Pajanidi, J. Podistov, G. Chemeris, L. Sozaeva, E. Lipova, et al. Age at menarche is not an independent risk factor for high-risk human papillomavirus infections and cervical intraepithelial neoplasia Int J STD AIDS, January 1, 2008; 19(1): 16 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vaccarella, R. Herrero, M. Dai, P. J.F. Snijders, C. J.L.M. Meijer, J. O. Thomas, P. T. Hoang Anh, C. Ferreccio, E. Matos, H. Posso, et al. Reproductive Factors, Oral Contraceptive Use, and Human Papillomavirus Infection: Pooled Analysis of the IARC HPV Prevalence Surveys. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2148 - 2153. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |